Galapagos | GLPG - PE Price to Earnings


Galapagos reported 3.14 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
argenx SE 43.02 11.67 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Biogen 14.02 4.63 Dec/2025
Genmab 17.14 4.39 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
GRIFOLS 16.81 28.19 Sep/2025
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Incyte 14.84 2.79 Dec/2025
Merck 20.56 7.18 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 17.85 2.11 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
UCB 29.7 5.52 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025